[Federal Register Volume 60, Number 159 (Thursday, August 17, 1995)]
[Notices]
[Page 42904]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-20341]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on May 24, 1995, Dupont
Pharmaceuticals, The Dupont Merck Pharmaceutical Company, 1000 Stewart
Avenue, Garden City, New York 11530, made application to the Drug
Enforcement Administration (DEA) for registration as a bulk
manufacturer of the basic classes of controlled substances listed
below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Oxycodone (9143).............................................. II
Hydrocodone (9193)............................................ II
Oxymorphone (9652)............................................ II
------------------------------------------------------------------------
The firm plans to manufacture these controlled substances to make
finished products.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the above application.
Any such comments or objections may be addressed to the Deputy
Assistant Administrator, Office of Diversion Control, Drug Enforcement
Administration, United States Department of Justice, Washington, DC
20537, Attention: DEA Federal Register Representative (CCR), and must
be filed no later than October 16, 1995.
Dated: August 10, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 95-20341 Filed 8-16-95; 8:45 am]
BILLING CODE 4410-09-M